Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

Delta CEO Ed Bastian Says We Remain Optimistic Max 10 Will Be Certified

– Reuters

byBenzinga Newsdesk

October 13, 2022

1 minute read

– Reuters

FDA
News

WHO Strategic Advisory Group Of Experts Interim Recommendation Supports Use Of Johnson & Johnson COVID-19 Vaccine As Booster

By Benzinga Newsdesk

December 9, 6:04 PM

Johnson & Johnson (NYSE:JNJ) (the Company) today announced the interim recommendation by the Strategic Advisory Group of Experts on Immunization (SAGE) for the World Health Organization (WHO) supporting the use

JNJ

Jim Cramer Says Fed Closer To Victory In Inflation Battle: Powell’s Likely ‘Made More Progress…Than Colleagues Want To Believe’

By Bhavik Nair

February 9, 10:18 PM

Prominent market commentator Jim Cramer said the Federal Reserve is closer to victory in tackling inflation than what…

BBBY

Wolfe Research Initiates Coverage On Root with Peer Perform Rating, Announces Price Target of $5

By Benzinga Newsdesk

August 17, 5:02 AM

Wolfe Research analyst Michael Zaremski initiates coverage on Root (NASDAQ:ROOT) with a Peer Perform rating and announces Price Target of $5.

ROOT

‘Arizona Brings In $21 Million In Marijuana Tax Revenue For July, With Recreational Sales Catching Up To Medical’ -Marijuana Moment

By Michael Horton

August 25, 12:57 PM

https://www.marijuanamoment.net/arizona-brings-in-21-million-in-marijuana-tax-revenue-for-jul

CGC

Delta CEO Ed Bastian Says We Remain Optimistic Max 10 Will Be Certified

Related Posts

WHO Strategic Advisory Group Of Experts Interim Recommendation Supports Use Of Johnson & Johnson COVID-19 Vaccine As Booster

Jim Cramer Says Fed Closer To Victory In Inflation Battle: Powell’s Likely ‘Made More Progress…Than Colleagues Want To Believe’

Wolfe Research Initiates Coverage On Root with Peer Perform Rating, Announces Price Target of $5

‘Arizona Brings In $21 Million In Marijuana Tax Revenue For July, With Recreational Sales Catching Up To Medical’ -Marijuana Moment